234 results on '"Hadinegoro, Sri Rezeki"'
Search Results
2. A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity
3. Safety profile of inactivated COVID-19 vaccine in indonesian adults
4. The Value of Warning Signs From the WHO 2009 Dengue Classification in Detecting Severe Dengue in Children
5. Proceedings of the 6th Asia Dengue Summit, June 2023
6. One-month follow up of a randomized clinical trial-phase II study in 6 to
7. Safety profile of inactivated COVID-19 in healthy adults aged ≥ 18 years: A passive surveillance in Indonesia
8. Birth prevalence and characteristics of congenital cytomegalovirus infection in an urban birth cohort, Jakarta, Indonesia
9. Zinc supplementation and cellular immune response in splenectomized thalassemia major.
10. Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction.
11. Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children
12. A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report
13. Pneumococcal vaccination for splenectomized patients with thalassemia major in Indonesia
14. Clinical Course and Management of Dengue in Children Admitted to Hospital: A 5 Years Prospective Cohort Study in Jakarta, Indonesia
15. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
16. Estimating dengue transmission intensity from serological data: A comparative analysis using mixture and catalytic models
17. DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
18. The Role of Angiopoietin-2 on Plasma Leakage in the Critical Phase and Convalescence of Dengue Virus Infection in Children
19. Immunogenicity and Safety in Healthy Adults of Full-Dose Versus Half Doses of COVID-19 Vaccine (ChAdOx1-S or BNT162b2) or Full-Dose CoronaVac Administered as a Booster Dose after Priming with Coronavac: A Randomized, Observer-Blinded, Controlled Trial Conducted in Indonesia
20. Estimating dengue transmission intensity from serological data: a comparative analysis using mixture and catalytic models.
21. Safety of a 2-dose primary series of 13-valent pneumococcal conjugate vaccine in Indonesian infants.
22. Stability of Zika Virus Antibodies in Specimens from a Retrospective Serological Study
23. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
24. Spatiotemporal Heterogeneity of Zika Virus Transmission in Indonesia: Serosurveillance Data from a Pediatric Population
25. Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
26. Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop
27. Diphtheria outbreak in Jakarta and Tangerang, Indonesia: Epidemiological and clinical predictor factors for death
28. Pneumococcal nasopharyngeal carriage in Indonesia infants and toddlers post-PCV13 vaccination in a 2+1 schedule: A prospective cohort study
29. The prevalence of pilus islets in Streptococcus pneumoniae isolates from healthy children in Indonesia
30. Jadwal Imunisasi Anak Umur 0 – 18 tahun Rekomendasi Ikatan Dokter Anak Indonesia Tahun 2020
31. First Pediatric Outpatient Parenteral Antibiotic Therapy Clinic in Indonesia
32. Absence of Evidence of Zika Virus Infection in Cord Blood and Urine from Newborns with Congenital Abnormalities, Indonesia
33. Spatiotemporal variability in dengue transmission intensity in Jakarta, Indonesia
34. Spatiotemporal Heterogeneity of Zika Virus Transmission in Indonesia: Sero surveillance Data from a Pediatric Population.
35. The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
36. Calculator and Prediction Score for Early-onset Neonatal Sepsis in Asymptomatic Term Infant: A Determinant Model
37. The Difference of sVE-Cadherin Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock
38. Post Marketing Surveillance Study of 2nd Dose Quadrivalent Human Papilloma Virus Vaccine in Elementary School Children in Jakarta, Indonesia: Safety Result and Implementation of School-Based HPV Immunization Program
39. Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine
40. Economic burden of dengue in Indonesia
41. Spatiotemporal Variability in Dengue Transmission Intensity in Jakarta, Indonesia
42. Geographic variation in dengue seroprevalence and force of infection in the urban paediatric population of Indonesia
43. The association of fatty acid desaturase gene polymorphisms on long-chain polyunsaturated fatty acid composition in Indonesian infants
44. Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
45. Spatiotemporal variability in dengue transmission intensity in Jakarta, Indonesia.
46. Safety profile of Td vaccination in Indonesian pregnant women: a post-marketing surveillance study.
47. Zika Virus Seropositivity in 1–4-Year-Old Children, Indonesia, 2014
48. Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries
49. Dengue virus serotype distribution based on serological evidence in pediatric urban population in Indonesia
50. Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.